TP53 and invasive ductal breast carcinoma: For instance, a Kaplan–Meier analysis of TNBC invasive ductal carcinoma samples showed that a positive p53 expression was correlated with worse overall survival (79.6% vs. 89.6%, log-rank test p = 0.025) and the patients had a 2.2 times higher mortality risk than that of p53-negative patients (HR: 2.222; 95% CI: 1.147–4.308) [102].